TY - JOUR
T1 - Economic Burden of Palmoplantar Pustulosis in Sweden
T2 - A Population-based Register Study
AU - Löfvendahl, Sofia
AU - Norlin, Jenny M.
AU - Schmitt-Egenolf, Marcus
PY - 2023
Y1 - 2023
N2 - The aim of this study was to estimate the economic burden of palmoplantar pustulosis, a chronic relapsing skin condition commonly occurring in combination with psoriasis vulgaris. Using data from the Swedish National Patient Register and Swedish Prescribed Drug Register for 2015, the study estimated all-cause and palmoplantar pustulosis-specific healthcare resource use (inpatient stays, physician visits and drug use) for 14,715 patients with palmoplantar pustulosis, and compared these both with matched controls from the general population and with patients with psoriasis vulgaris (without palmoplantar pustulosis). Mean an-nual direct costs for a patient with palmoplantar pustu-losis was higher compared with costs for the general population (3,000 vs 1,700 Euro, p < 0.001). Compared with psoriasis vulgaris, more patients with palmoplan-tar pustulosis had inpatient stays, but fewer had physician visits and psoriasis-related drugs; the overall costs were similar. Only a small fraction of the costs of physician visits and inpatient stays for patients with palmoplantar pustulosis were attributable to specific palmoplantar pustulosis problems, indicating a clear comorbidity burden in palmoplantar pustulosis.
AB - The aim of this study was to estimate the economic burden of palmoplantar pustulosis, a chronic relapsing skin condition commonly occurring in combination with psoriasis vulgaris. Using data from the Swedish National Patient Register and Swedish Prescribed Drug Register for 2015, the study estimated all-cause and palmoplantar pustulosis-specific healthcare resource use (inpatient stays, physician visits and drug use) for 14,715 patients with palmoplantar pustulosis, and compared these both with matched controls from the general population and with patients with psoriasis vulgaris (without palmoplantar pustulosis). Mean an-nual direct costs for a patient with palmoplantar pustu-losis was higher compared with costs for the general population (3,000 vs 1,700 Euro, p < 0.001). Compared with psoriasis vulgaris, more patients with palmoplan-tar pustulosis had inpatient stays, but fewer had physician visits and psoriasis-related drugs; the overall costs were similar. Only a small fraction of the costs of physician visits and inpatient stays for patients with palmoplantar pustulosis were attributable to specific palmoplantar pustulosis problems, indicating a clear comorbidity burden in palmoplantar pustulosis.
KW - economic burden
KW - epidemiology
KW - healthcare register
KW - healthcare resource use
KW - palmoplantar pustulosis
KW - population-based
U2 - 10.2340/actadv.v103.4501
DO - 10.2340/actadv.v103.4501
M3 - Article
C2 - 36621923
AN - SCOPUS:85145970985
SN - 0001-5555
VL - 103
JO - Acta Dermato-Venereologica
JF - Acta Dermato-Venereologica
M1 - adv00843
ER -